Stock COMBIMATRIX CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News CombiMatrix Corp

Equities

US20009T5011

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation
GL
CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results
GL
CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation
GL
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation
GL
CombiMatrix to Present New Data from a Large-Scale Analysis of Genomic Abnormalities Impacting Multiple Stages of Human Growth and Development Starting from Conception through Childhood at the American Society of Human Genetics Annual Meeting
GL
CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae
GL
CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results
GL
CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock
GL
CombiMatrix to Present at Upcoming Investor Conferences
GL
CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results
GL
CombiMatrix Corporation to Release 2017 First Quarter Financial Results on May 4, 2017
GL
CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
GL
CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
GL
CombiMatrix Corporation to Release 2016 Fourth Quarter and Full Year Financial Results on February 22, 2017
GL
CombiMatrix to Present at 2nd Annual Disruptive Growth & Healthcare Conference
GL
CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board
GL
CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss
GL
CombiMatrix : Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health
PU
CombiMatrix’s Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health
GL
CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News CombiMatrix Corp